Mednet Logo
CommunityNeurosurgery

How do you manage disease progression during adjuvant chemoradiotherapy for glioblastoma?

Under what circumstances would you discontinue or alter therapy?
Community PollStarted

How do you manage symptomatic progression during chemoradiotherapy for a glioblastoma?

126 physicians have voted

Join Mednetto vote and see how they answered.

4 Answers
Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · University of Florida
Answered on

Hospice.

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Radiation Oncology · St. Anne's Hospital
Answered on

I agree with @Dr. First Last. This is not a “single best answer” question.

First, I’ll pose a question of my own: do you check the “radical” or “palliative” box in your prescription? I have never had a patient achieve permanent NED status, so I view our role as aggressive palliation.

As @Dr. First L...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Radiation Oncology · Vanderbilt-Ingram Cancer Center
Answered on

How are you defining disease progression during chemoradiation? If just radiographic, I would treat on. If clinical, I would consider transitioning to hypofrac (if not already doing so) and completing treatment.

If very early on in the course, and disease is resectable (say early recurrence between ...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Neurology · Hartford Healthcare Cancer Institute
Answered on

As a clinical practice matter, I strongly doubt true progression during chemoradiation therapy and have no "stronger" treatment options that would be more cytocidal. I typically manage symptoms and proceed with the planned course of RT.

Radiographic progression during treatment is expected and reflec...

Join for free or sign in to see the full answer